Results 221 to 230 of about 285,083 (269)
Some of the next articles are maybe not open access.
Biomarkers of Immunosuppression
Critical Care Clinics, 2020It is now recognized that sepsis is not a uniformly proinflammatory state. There is a well-recognized counter anti-inflammatory response that occurs in many patients. The timing and magnitude of this response varies considerably and thus makes its identification and manipulation more difficult.
Abinav K, Misra +2 more
openaire +2 more sources
Clinics in Liver Disease, 2000
The current treatment of posttransplant lymphoproliferative disease (PTLD) includes prophylaxis at the time of transplant, decreasing or stopping immunosuppresion and initiation of antiviral therapy in patients with polymerase chain reaction or clinical evidence of PTLD, and judicial reintroduction of immunosuppression in patients who have cleared ...
D C, Cronin +6 more
openaire +2 more sources
The current treatment of posttransplant lymphoproliferative disease (PTLD) includes prophylaxis at the time of transplant, decreasing or stopping immunosuppresion and initiation of antiviral therapy in patients with polymerase chain reaction or clinical evidence of PTLD, and judicial reintroduction of immunosuppression in patients who have cleared ...
D C, Cronin +6 more
openaire +2 more sources
[Pharmacogenetics of immunosuppressants].
Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia, 2015Individualized drug therapy with immunosuppressants is an hot topic in transplantation. Therapeutic drug monitoring (TDM) is currently utilized to guide therapy, but toxic or subtherapeutic concentrations can only be identified after the drug is administered.
Cojutti P. G., Baraldo M.
openaire +3 more sources
Immunosuppression on the Horizon
Heart Failure Clinics, 2007Many novel immunosuppressive agents are under active clinical investigation. In addition, creative approaches are being developed for the use of established immunosuppressive agents, with the goal of minimizing immunosuppression as early as possible posttransplantation.
openaire +2 more sources
Mechanisms of immunosuppression
Veterinary Immunology and Immunopathology, 1991Immunosuppresive disease is a major economic concern in domestic poultry production. Although many immunosuppressive agents have been described, mechanisms of how infectious and noninfectious agents compromise the immune system are poorly understood in avian species. Two categories, generalized and antigen-specific immunosuppression have been described
openaire +2 more sources
Ophthalmology Clinics of North America, 2002
The treatment of ocular inflammatory disease continues to be a major challenge as the clinician tries to balance the risks and the benefits of immunosuppressive therapy. Currently, corticosteroids, antimetabolites, and calcineurin inhibitors are the most commonly used agents.
Ali R, Djalilian, Robert B, Nussenblatt
openaire +2 more sources
The treatment of ocular inflammatory disease continues to be a major challenge as the clinician tries to balance the risks and the benefits of immunosuppressive therapy. Currently, corticosteroids, antimetabolites, and calcineurin inhibitors are the most commonly used agents.
Ali R, Djalilian, Robert B, Nussenblatt
openaire +2 more sources
Current Opinion in Organ Transplantation, 2012
Elika, Derek, Kiran, Dhanireddy
openaire +2 more sources
Elika, Derek, Kiran, Dhanireddy
openaire +2 more sources